Option Care Health Announces Financial Results For the Third Quarter Ended September 30, 2025

Rhea-AI Summary

Option Care Health (Nasdaq: OPCH) reported third-quarter 2025 results for the period ended September 30, 2025: net revenue $1.435B (+12.2% YoY), gross profit $272.9M (+6.3% YoY), net income $51.8M (-3.8% YoY) and GAAP diluted EPS $0.32. Adjusted metrics: Adjusted EBITDA $119.5M (+3.4% YoY) and Adjusted diluted EPS $0.45 (+9.8% YoY). The company repurchased $62.5M of stock in the quarter, expanded a term loan by $49.6M with a lower rate, and reported YTD operating cash flow of $222.6M.

Updated 2025 guidance: revenue $5.60–5.65B, Adjusted EPS $1.68–1.72, Adjusted EBITDA $468–473M, and cash flow from operations ≥ $320M.

Positive

• Net revenue +12.2% YoY to $1.435B
• Adjusted EBITDA +3.4% YoY to $119.5M
• Adjusted diluted EPS +9.8% YoY to $0.45
• Share repurchases of $62.5M in the quarter
• Updated full-year revenue guide $5.60–5.65B

Negative

• Net income down 3.8% YoY to $51.8M
• YTD operating cash flow $222.6M vs guidance ≥$320M
• Total liabilities increased to $2.121B from $2.017B (Dec 31, 2024)
• Cash and cash equivalents declined to $309.8M from $412.6M (Dec 31, 2024)

Insights

Senior Healthcare Finance Analyst

Strong top‑line growth and modest margin expansion; adjusted metrics and guidance point to continued operational recovery.

Revenue increased to $1,435.0 million in Q3, up 12.2%, with gross profit rising to $272.9 million (up 6.3%). Adjusted EBITDA of $119.5 million (up 3.4%) and adjusted diluted EPS of $0.45 (up 9.8%) show the business converting higher volumes into improved non‑GAAP profitability despite a slight GAAP net income decline of 3.8%.

Key dependencies include sustained revenue mix and reimbursement dynamics, plus interest and financing costs after the term loan expansion and rate reduction. Management provided full year 2025 guidance of $5.60–$5.65 billion revenue and adjusted EBITDA of $468–$473 million, which creates a clear near‑term check for performance; monitor quarterly cash flow and net interest expense (~$55–$57 million) over the remainder of 2025.

BANNOCKBURN, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2025.

Third Quarter 2025 Financial Highlights

(Year-over-year comparisons unless otherwise noted)

• Net revenue of $1,435.0 million, up 12.2%
• Gross profit of $272.9 million, up 6.3%
• Net income of $51.8 million, down 3.8%
• GAAP diluted earnings per share of $0.32, up 3.2%
• Adjusted EBITDA of $119.5 million, up 3.4%
• Adjusted diluted earnings per share of $0.45, up 9.8%
• YTD cash provided by operating activities of $222.6 million
• Repurchased $62.5 million of stock in the quarter
• Term loan expanded $49.6 million, and interest rate reduced

John C. Rademacher, Chief Executive Officer, commented, “The Option Care Health team delivered another strong quarter with balanced growth across the portfolio. I’d like to thank our team for their extraordinary execution and continued dedication to providing access to quality care to more patients. We are well positioned for success as we continue to navigate a dynamic regulatory environment, changing competitive landscapes, and our evolving portfolio of therapies while always keeping the patient at the center of everything we do.”

Updated Full Year 2025 Financial Guidance

For the full year 2025, Option Care Health now expects to generate:

• Net revenue of $5.60 billion to $5.65 billion
• Adjusted diluted earnings per share of $1.68 to $1.72
• Adjusted EBITDA of $468 million to $473 million
• Cash flow from operations of at least $320 million
• Effective tax rate of 25% to 27%
• Net interest expense of approximately $55 million to $57 million

Conference Call

Option Care Health will host a conference call to discuss its results on Thursday, October 30, 2025, at 8:30 a.m. ET. The conference call can be accessed via a live audio webcast that will be available online at investors.optioncarehealth.com. A replay of the call will be available at the same web link for 90 days after the call.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.

Investor Contact

Stephen Shulstein

Vice President, Investor Relations

stephen.shulstein@optioncare.com

Forward-Looking Statements - Safe Harbor

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements we may make regarding future revenues, future earnings, regulatory developments, market developments, new products and growth strategies, integration activities and the effects of any of the foregoing on our future results of operations or financial conditions.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: changes in laws and regulations applicable to our business model; changes in market conditions and receptivity to our services and offerings; pending and future litigation; potential liability for claims not covered by insurance; and loss of relationships with managed care organizations and other non-governmental third party payers. For a detailed discussion of the risk factors that could affect our actual results, please refer to the risk factors identified in our periodic reports as filed with the SEC.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

Note Regarding Use of Non-GAAP Financial Measures

In addition to reporting financial information in accordance with generally accepted accounting principles (GAAP), the Company is also reporting Adjusted net income, Adjusted EBITDA and Adjusted diluted earnings per share ("Adjusted EPS"), which are non-GAAP financial measures. These adjusted measures are not measurements of financial performance under GAAP and should not be used in isolation or as a substitute or alternative to net income, earnings per share, or any other performance measure derived in accordance with GAAP, or as a substitute or alternative to cash flow from operating activities or a measure of the Company’s liquidity. In addition, the Company's definitions of Adjusted net income, Adjusted EBITDA, and Adjusted diluted EPS may not be comparable to similarly titled non-GAAP financial measures reported by other companies. As defined by the Company: (i) Adjusted net income represents net income before intangible asset amortization expense, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, net of tax adjustments, (ii) Adjusted EBITDA represents net income before net interest expense, income tax expense, depreciation and amortization, stock-based compensation expense, loss on extinguishment of debt, and restructuring, acquisition, integration and other expenses, and (iii) Adjusted diluted earnings per share represents Adjusted net income divided by weighted average common shares outstanding, diluted. As part of restructuring, acquisition, integration and other expenses, the Company may incur significant charges such as the write down of certain long‑lived assets, temporary redundant expenses, professional fees, certain litigation expenses and reserves related to acquired businesses, potential retention and severance costs and potential accelerated payments or termination costs for certain of its contractual obligations. Management believes that these adjusted measures provide useful supplemental information regarding the performance of Option Care Health’s business operations and facilitate comparisons to the Company’s historical operating results. We have not reconciled Adjusted EBITDA or Adjusted diluted earnings per share guidance to net income as management believes creation of this reconciliation would not be practicable due to the uncertainty regarding, and potential variability of, material reconciling items. Full reconciliations of each adjusted measure to the most comparable GAAP financial measure are set forth below.

  Schedule 1

OPTION CARE HEALTH, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(IN THOUSANDS)(UNAUDITED)

	September 30, 2025			December 31, 2024
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	309,822		$	412,565
Accounts receivable, net		474,500			409,733
Inventories		415,723			388,131
Prepaid expenses and other current assets		82,721			112,198
Total current assets		1,282,766			1,322,627
NONCURRENT ASSETS:
Property and equipment, net		134,298			127,367
Intangible assets, net		22,732			16,993
Referral sources, net		295,716			284,017
Goodwill		1,606,646			1,540,246
Other noncurrent assets		137,687			130,493
Total noncurrent assets		2,197,079			2,099,116
TOTAL ASSETS	$	3,479,845		$	3,421,743
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Accounts payable	$	627,867		$	610,779
Other current liabilities		196,039			169,367
Total current liabilities		823,906			780,146
NONCURRENT LIABILITIES:
Long-term debt, net of discount, deferred financing costs and current portion		1,155,056			1,104,641
Other noncurrent liabilities		142,224			132,718
Total noncurrent liabilities		1,297,280			1,237,359
Total liabilities		2,121,186			2,017,505
STOCKHOLDERS’ EQUITY		1,358,659			1,404,238
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	3,479,845		$	3,421,743

Schedule 2

OPTION CARE HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED)

	Three Months Ended September 30,								Nine Months Ended September 30,
		2025				2024				2025				2024
NET REVENUE	$	1,435,016			$	1,278,546			$	4,184,073			$	3,651,784
COST OF REVENUE		1,162,114				1,021,797				3,379,076				2,907,170
GROSS PROFIT		272,902				256,749				804,997				744,614
OPERATING COSTS AND EXPENSES:
Selling, general and administrative expenses		172,104				156,999				510,314				465,524
Depreciation and amortization expense		16,291				14,659				48,278				44,294
Total operating expenses		188,395				171,658				558,592				509,818
OPERATING INCOME		84,507				85,091				246,405				234,796
OTHER INCOME (EXPENSE):
Interest expense, net		(14,146	)			(12,345	)			(41,824	)			(38,150	)
Other, net		(1,394	)			808				(3,197	)			5,904
Total other (expense) income		(15,540	)			(11,537	)			(45,021	)			(32,246	)
INCOME BEFORE INCOME TAXES		68,967				73,554				201,384				202,550
INCOME TAX EXPENSE		17,151				19,698				52,303				50,860
NET INCOME	$	51,816			$	53,856			$	149,081			$	151,690
Earnings per share, basic	$	0.32			$	0.32			$	0.91			$	0.88
Earnings per share, diluted	$	0.32			$	0.31			$	0.91			$	0.87
Weighted average common shares outstanding, basic		161,829				170,636				163,393				172,490
Weighted average common shares outstanding, diluted		163,086				171,941				164,602				173,848

Schedule 3

OPTION CARE HEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)(UNAUDITED)

	Nine Months Ended September 30,
		2025				2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	149,081			$	151,690
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization expense		50,374				46,029
Other adjustments		57,401				54,926
Changes in operating assets and liabilities:
Accounts receivable, net		(55,430	)			(51,293	)
Inventories		(24,899	)			(36,595	)
Prepaid expenses and other current assets		24,694				(3,175	)
Accounts payable		10,224				164,754
Accrued compensation and employee benefits		8,338				(31,673	)
Other		2,773				(7,393	)
Net cash provided by operating activities		222,556				287,270
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of property and equipment		(27,661	)			(25,266	)
Business acquisitions, net of cash acquired		(117,247	)			—
Other investing activities		(2,529	)			—
Net cash used in investing activities		(147,437	)			(25,266	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Purchase of company stock and related excise taxes		(214,887	)			(160,122	)
Proceeds from issuance of debt		229,472				49,959
Retirement of debt obligations		(180,239	)			—
Other financing activities		(12,208	)			(12,664	)
Net cash used in financing activities		(177,862	)			(122,827	)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS		(102,743	)			139,177
Cash and cash equivalents - beginning of the period		412,565				343,849
CASH AND CASH EQUIVALENTS - END OF PERIOD	$	309,822			$	483,026

Schedule 4

OPTION CARE HEALTH, INC.
QUARTERLY RECONCILIATION BETWEEN GAAP AND NON-GAAP MEASURES
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)(UNAUDITED)

	Three Months Ended September 30,								Nine Months Ended September 30,
		2025				2024				2025				2024
Net income	$	51,816			$	53,856			$	149,081			$	151,690
Interest expense, net		14,146				12,345				41,824				38,150
Income tax expense		17,151				19,698				52,303				50,860
Depreciation and amortization expense		17,048				15,227				50,374				46,029
EBITDA		100,161				101,126				293,582				286,729
EBITDA adjustments
Stock-based incentive compensation expense		11,125				10,407				30,638				27,620
Loss on extinguishment of debt		4,744				—				4,744				377
Restructuring, acquisition, integration and other		3,468				4,050				16,318				7,504
Adjusted EBITDA	$	119,498			$	115,583			$	345,282			$	322,230
Net income	$	51,816			$	53,856			$	149,081			$	151,690
Intangible asset amortization expense		9,269				8,596				27,663				25,809
Stock-based incentive compensation expense		11,125				10,407				30,638				27,620
Loss on extinguishment of debt (2)		4,744				—				4,744				—
Restructuring, acquisition, integration and other		3,468				4,050				16,318				7,504
Total pre-tax adjustments		28,606				23,053				79,363				60,933
Tax adjustments (1)		(7,183	)			(6,178	)			(20,634	)			(15,294	)
Adjusted net income	$	73,239			$	70,731			$	207,810			$	197,329
Earnings per share, diluted	$	0.32			$	0.31			$	0.91			$	0.87
Adjusted earnings per share, diluted	$	0.45			$	0.41			$	1.26			$	1.14
Weighted average common shares outstanding, diluted		163,086				171,941				164,602				173,848

_{(1) Tax adjustments for the three and nine months ended September 30, 2025 and 2024 include the estimated income tax effect on non-GAAP adjustments based on the effective tax rate}

_{(2) Beginning with the three months ended September 30, 2025, adjusted net income excludes loss on extinguishment of debt on a prospective basis, which has been immaterial in prior periods.}

FAQ

What were Option Care Health (OPCH) Q3 2025 revenues and growth?

Option Care Health reported Q3 2025 net revenue of $1.435 billion, up 12.2% year-over-year.

How did OPCH perform on profitability in Q3 2025?

GAAP net income was $51.8 million (down 3.8% YoY) and Adjusted EBITDA was $119.5 million (up 3.4% YoY).

What guidance did Option Care Health give for full-year 2025 (OPCH)?

Full-year 2025 guidance is $5.60–5.65 billion revenue, Adjusted EPS $1.68–1.72, and Adjusted EBITDA $468–473 million.

How much share repurchase did OPCH complete in Q3 2025?

Option Care Health repurchased $62.5 million of common stock during Q3 2025.

What cash flow and debt changes did OPCH report through Q3 2025?

YTD cash provided by operations was $222.6 million; the company expanded a term loan by $49.6 million and reduced its interest rate.